Results 191 to 200 of about 153,000 (334)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia [PDF]

, 1999
Marc Hendrikx, Hui Jiang, H. Gutermann, Jerry R. Toelsie, Didier Renard, A. Briersb, J.L. Pauwelsb, Urbain Mees   +7 more
openalex   +1 more source

Cardiac Troponin I Biosensors: Innovations in Real-Time Diagnosis of Cardiovascular Diseases. [PDF]

Anal Sci Adv
Ebrahimi S, Alivirdiloo V, Hajiabbasi M, Masoumi S, Mohammadi M, Hosseini S, Gargari SO, Mobed A.   +7 more
europepmc   +1 more source

Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma [PDF]

, 1995
Sylvie Trinquier, O Flécheux, M Bullenger, F. Castex   +3 more
openalex   +1 more source

GEO combined with quantitative protein trait loci identify causative proteins in hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is a rare genetic heart disease characterized by a limited patient population and scarce research and treatment resources. This study aimed to identify HCM‐associated proteins by integrating cardiac tissue data from the Gene Expression Omnibus (GEO) database with the latest protein quantitative trait ...
Bo Li, Xu Zhao, Yan Ding, Yi Zhang
wiley   +1 more source

Optimizing Cardiovascular Assessment: Reducing Unnecessary Cardiac Troponin I Testing. [PDF]

Glob Heart
Fernandes A, Wisnivesky ACT, Rezende R, Cardozo FAM, Gualandro DM, Calderaro D, Fornari L, Antonangelo L, Sumita N, Strunz C, Bichuette LD, Lottenberg MP, Caramelli B.   +12 more
europepmc   +1 more source

Troponin I release during minimally invasive coronary artery surgery [PDF]

, 1997
Inderpaul Birdi, Massimo Caputo, J.A. Hutter, A J Bryan, Gianni D. Angelini   +4 more
openalex   +1 more source

Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims As a special type of hypertrophic cardiomyopathy (HCM), apical HCM (ApHCM) has different clinical characteristics while its nature history and prognosis are not well recognized. We aimed to describe the characteristics and outcomes of ApHCM and identify predictors of adverse outcomes.
Meng Guo, Chuanfen Liu, Jingjing Ye, Jian Liu   +3 more
wiley   +1 more source

Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases. [PDF]

Biomolecules
Zhang N, Wang Y, Li F, Zhu Y, Fu Z, Jia M, Zhan X, Zhang W.   +7 more
europepmc   +1 more source

Acute myocarditis according to age: Presentation, management and early outcomes

ESC Heart Failure, EarlyView.
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty, Paul Vignaud, Clara Brusq, Pamela Moceri, Pascal Lim, Edouard Gerbaud, Olivier Lairez, Coline Lelarge, Caroline Ovaert, Claire Bouleti, Oscar Werner, Vanina Bongard, Thibaud Genet, Laurent Bonnemains, Christophe Tron, Elise Barre, Margaux Boddaert, Jacques Mansourati, Chérine Benzouid, François Roubille, Hadi Khachab, Sabrina Uhry, Ariel Cohen, Benoit Lattuca, Sylvie Di Filippo, Clément Delmas   +25 more
wiley   +1 more source